Montgomery SA, Judge R. Treatment of depression with associated anxiety: comparisons of
tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand …

The prevalence of depression and concomitant anxiety is high in the community. Patients
with depression and concomitant anxiety experience increased functional disability …

Zohar J, Westenberg HGM. Anxiety disorders: a review of tricyclic antidepressants and
selective serotonin reuptake inhibitors. Acta Psychiatr Scand 2000: 101: 39–49.© …

Patients suffering from anxiety and depression are often seen in clinical practice. In
accordance with the diagnostic criteria of DSM-III/IV and ICD-10, respectively, there may be …

The overlap between the depressive and anxiety disorders is extremely common. The
introduction of the selective serotonin reuptake inhibitors (SSRIs) has, more than any other …

The syndromes of anxiety and depression may reflect separate disorders with overlapping
symptoms. They also may be comorbid or reflect illnesses with similar underlying …

Depressive and anxiety disorders have a high lifetime prevalence--8% and 15%,
respectively. Unipolar depression has a 5% lifetime prevalence, whereas the prevalence …

Peretti S, Judge R, Hindmarch I. Safety and tolerability considerations: tricyclic
antidepressants vs. selective serotonin reuptake inhibitors. Acta Psychiatr Scand 2000: 101 …

The selective serotonin reuptake inhibitors (SSRIs) are recognized as effective as and better
tolerated than older antidepressant therapies and have become the drugs of choice in the …

A meta‐analysis of the efficacy and tolerability of selective serotonin reuptake inhibitors
(SSRIs) against nonselective and noradrenergic reuptake inhibitors (mainly tricyclic …